EPW
TEVA icon

Evergreen Private Wealth’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Evergreen Private Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-359
Closed -$6.02K – 292
2025
Q2 		$6.02K Hold
359
– – ﹤0.01% 173
2025
Q1 		$5.52K Buy
+359
New +$6.41K ﹤0.01% 162

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Evergreen Private Wealth's TEVA Position: Q3 2025 in Review

Evergreen Private Wealth sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2025, closing a stake of 359 shares — an estimated $6.02K sold.

Evergreen Private Wealth first reported a position in TEVA in Q1 2025 and held it in 2 quarters. The position peaked at $6.02K in Q2 2025. 553 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Evergreen Private Wealth reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2025 after selling out during the quarter.
  • Evergreen Private Wealth sold 359 Teva Pharmaceutical Industries Limited shares in Q3 2025, an estimated $6.02K.
  • Evergreen Private Wealth first reported a position in Teva Pharmaceutical Industries Limited in Q1 2025 and held it in 2 quarters.
  • Evergreen Private Wealth's Teva Pharmaceutical Industries Limited position peaked at $6.02K in Q2 2025.
  • 553 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2025.

Based on Evergreen Private Wealth's 13F filing for Q3 2025, filed 24 Oct 2025.